Skip to content Skip to footer
1 - 8 out of 8Page size: 10
8 Research output

2024

2022

2021

2020

  • Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology

    Dantes, Z., Yen, H.-Y., Pfarr, N., Winter, C., Steiger, K., Muckenhuber, A. & Hennig, A. & 40 others, Lange, S., Engleitner, T., Oellinger, R., Maresch, R., Orben, F., Heid, I., Kaissis, G., Shi, K., Topping, G., Stoegbauer, F., Wirth, M., Peschke, K., Papargyriou, A., Rezaee-Oghazi, M., Feldmann, K., Schaefer, A. P. G., Ranjan, R., Lubeseder-Martellato, C., Stange, D. E., Welsch, T., Martignoni, M., Ceyhan, G. O., Friess, H., Herner, A., Liotta, L., Treiber, M., Figura, G. V., Abdelhafez, M., Klare, P., Schlag, C., Alguel, H., Siveke, J., Braren, R., Weirich, G., Weichert, W., Saur, D., Rad, R., Schmid, R. M., Schneider, G. & Reichert, M., 6 Aug 2020, In: JCI insight. 12 p.

    Research output: Contribution to journalResearch articleContributedpeer-review

    Published
  • Strategic option pricing

    Bieta, V., Broll, U. & Siebe, W., 1 Aug 2020, In: Economics and Business Review. 6, 3, p. 118-129 12 p.

    Research output: Contribution to journalResearch articleContributedpeer-review

    Published

2019

2011